# Antiarrhythmic Effects of Spironolactone in Patients With ICDs

> **NCT04495712** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 90 (actual)

## Conditions studied

- Ventricular Arrhythmias

## Interventions

- **DRUG:** spironolactone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04495712
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07-28
- **Primary completion:** 2008-05-28
- **Final completion:** 2008-05-28
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04495712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04495712, "Antiarrhythmic Effects of Spironolactone in Patients With ICDs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04495712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*